Dry Eyes

This blog has been contributed by Dr. Alia Issa, General Ophthalmologist at Moorfields Eye Hospital Dubai 


Dry eye is one of the most common reasons to visit an ophthalmologist. It is estimated that around 75% of people worldwide suffer from some dry eye at some point in their life.

What causes dry eye?

Environmental factors like air conditioning, air pollution, cigarette smoke, contact lens use, dusty and hot weather, and extended computer and smartphone use can contribute to dry eye and ultimately worsen symptoms. But also gender and age, systemic diseases, especially autoimmune diseases and medications play an essential role in developing dry eye disease.

What are the symptoms?

Symptoms can include foreign body sensation, pain, itchiness, tearing, redness of the eyes and blurry vision.

How do we diagnose dry eye?

When diagnosing a dry eye we differentiate between two main types of dry eye i.e. evaporative dry eye and aqueous deficient dry eye. Evaporative dry eye means that the tear film evaporates from the ocular surface faster than it should. In contrast, aqueous deficient dry eye describes a condition where tear production is reduced. Both have different underlying causes, which require different treatment approaches.

How do we treat dry eye?

Dry Eye is a complex disease; very often, it is not one but multiple factors that contribute to it. Therefore, a detailed history, slit lamp examination and special diagnostic tests are vital in finding the right individual treatment approach for each patient. Treatment options can vary from lifestyle changes, different types of artificial tears, and tear plugs to in-office treatments like Intense Pulse Light (IPL) and Lipiflow, depending on the underlying causes of the dry eye.

At Moorfields Eye Hospital Dubai, we can tailor an individual treatment plan for each patient. If you feel you are experiencing dry eye symptoms, we recommend you visit a specialist to get a professional diagnosis and treatment if required.

PAUL implant- the latest in aqueous shunt device insertion surgery for advanced glaucoma

This blog has been contributed by the Moorfields Eye Hospital Dubai Glaucoma Team (Dr. Salman Waqar and Dr. Mohamed Sayed), who were the first in Dubai to insert the PAUL Implants in adults and children.

Glaucoma affects a significant percentage of the population worldwide, and the risk increases with age. The non-surgical treatment options available for most patients are medications to reduce pressure in the eye and laser trabeculoplasty, which targets the drainage angle of the eye.


However, for many patients with advanced glaucoma or complex secondary glaucoma, medications and laser treatments alone are not sufficient to control eye pressure and preserve vision.

In these circumstances, aqueous tube shunts (also known as aqueous shunt devices or glaucoma drainage devices) have a much broader range of efficacy even in patients with the highest risk.

The devices in common use are the Ahmed Valve and the Baerveldt Tube.

Now, at Moorfields Eye Hospitals UAE, we also offer surgery with the latest device known as the PAUL implant.

What is the PAUL implant?

The PAUL implant is the latest generation of aqueous shunt devices. It has been designed to optimize efficacy with a higher safety profile. It is composed of a soft tube that is inserted into the eye and drains away excess fluid thereby controlling the eye pressure. The diameter of this tube is less than half a millimeter and this prevents complications such as low pressure or corneal damage. The tube is connected to a thin and soft end-plate which is placed under the skin of the eye. This end-plate is very comfortable and causes no erosion or discomfort. It also does not degrade and lasts for the duration of the patient’s lifetime.

How does it work?

Glaucoma is most commonly associated with a build-up of fluid pressure inside the eye. This build-up of fluid pressure is caused by partial blockage of the natural drainage channel of the eye. This pressure can damage the optic nerve which carries images from the eye to the brain affecting your vision. This fluid produced inside your eye is called aqueous humour, which is different from your tears. The PAUL implant drains fluid from inside the eye to an end-plate on the outside, which is placed under a thin skin-like membrane covering the white of the eye called the conjunctiva. The fluid is then absorbed into the bloodstream.

What are the benefits?

The PAUL implant will lower your eye pressure and prevent further damage to the optic nerve caused by eye pressure (intraocular pressure). Its design ensures less chance of complications such as low IOP (hypotony), corneal damage and tube erosion, and a more predictable eye pressure control from the very first day after the surgery.

Are there any alternatives?

The closest alternatives to the PAUL implant are the traditional aqueous shunt implants such as the Baerveldt or Ahmed Implants. We aim to always individualise treatment options to your unique needs and will suggest the PAUL implant to you only if we feel it offers the best chance of controlling your eye pressure compared to other techniques.


Moorfields Eye Hospital Dubai receives Accreditation from Joint Commission International

Dubau, United Arab Emirates,  6th July 2022 Moorfields Eye Hospital Dubai has earned Joint Commission International’s (JCI) Gold Seal of Approval® for Ambulatory Care Accreditation by demonstrating continuous compliance with its internationally-recognised standards.

Moorfields Eye Hospital Dubai underwent a rigorous on-site survey in June of 2022. During the survey, a Joint Commission International expert surveyor evaluated compliance with ambulatory care standards related to a variety of areas, including the International Patient Safety Goals, patient assessment and care, anaesthesia and surgical care, medication management, patient and family education, quality improvement, infection prevention and control, governance and leadership, facility management, staff qualifications and education, and information management.

“To receive accreditation from Joint Commission International is a true testament to our vision to be the finest eye hospital in the region and our mission to continuously operate to the highest clinical standards,” noted Elhadi Hassan, Managing Director of Moorfields Eye Hospitals UAE.  “Employees from across the organisation worked together to implement approaches and strategies to improve all areas of quality and the outcome is a testament to the hard work of every individual in the organization, and one that we are proud of.”

Dr. Ammar Safar, Medical Director, noted: “I was thrilled to see the decision by the Joint Commission International awarding Moorfield’s Eye Hospital Dubai its seal of approval without any findings.  This is a truly humbling testament of the superb quality service provided at Moorfields by a world-renowned international quality organisation.  This JCI certification has certainly raised the bar for us to continue our work and affirm our commitment to the highest standard of patient safety and outstanding outcomes.”

Maha Aboughali, Business Development and Marketing Director, added: “We are proud of the standards of excellence adopted by Moorfields Eye Hospital Dubai, which fall directly in line with Vision 2021 of the UAE, to be at the forefront in providing healthcare of the highest international standards for citizens and residents. Receiving accreditation from the Joint Commission International is one of our many goals and aspirations in our quest to solidify our position as a world leading provider of eye care in the region.”

Panretinal laser photocoagulation for Diabetic Retinopathy

This  blog has been contributed Dr. Fahd Quhill, Consultant Ophthalmologist in Medical Retina and Ocular inflammatory disease

Panretinal laser photocoagulation is gold standard for treating proliferative diabetic retinopathy; it is still the only available treatment that will provide a diabetic patient with long term regression of their diabetic changes and prevent further vision impairment.

What does laser treatment involve?

Dilating drops will be instilled on the day, to dilate your pupils with additional drops given by the nurse to numb the surface of the eye. Then the doctor will position you at the laser, whereby a contact lens will be placed on the front of the eye to keep the eyelids open and to allow the doctor to visualize the back of the eye and apply the required laser beams accordingly. It is important you keep still during the procedure and listen carefully and follow the instructions given by the doctor. It normally takes 10 to 20 minutes to complete a laser treatment, all dependent on the type of laser and number of laser burns the doctor needs to apply.

Is laser painful?

Some patient do feel some discomfort; it is normally a pricking sensation that they can perceive when certain areas of the retina are treated.

How long will it take my vision to recover?

Normally immediately after the laser, your vision will be dark, this is normal and not a cause for concern; it is due to the back of the eye being exposed to the light. Within a few minutes it will clear, but it will take up to 24 hours for your vision to return to its previous level where you will be able to resume your normal daily activities.

You may experience mild eye ache after laser, and there is no harm in taking mild painkillers to help with the discomfort.

You also may notice a few floaters within the vision, which do eventually improve and settle with time.

What are the side effects of panretinal laser photocoagulation for diabetic retinopathy?

Well for effective treatment, we need treat to the peripheral areas of the retina to regress the abnormal changes and stabiles vision. But within the peripheral retina, the cells that are important for your peripheral vision and night vision reside. So you may notice a reduction in your night vision, and perceive changes within the peripheral field, often this settles with time and you quickly adapt. However these side effects commonly occur in patients who have received multiple laser treatments for diabetic retinopathy.

Also occasionally if you have pre-existing diabetic maculopathy, leakage or swelling at the central vision, panretinal laser can worsen these changes leading to blurred vision. Often this is self-limiting and it will spontaneously resolve, but occasionally intravitreal injections into the eye are required to reduce leakage and rehabilitate your vision.

Don’t forget?

We cannot always guarantee stabilsation and regression of your diabetic changes with a single laser treatment, often patients will require multiple laser treatments to achieve this goal. Or patients ocular condition needs intravitreal injections to be combined with retinal laser for the best results and visual outcome.


Progressive Myopia Management

Glasses or contact lenses are prescribed to aid your child’s vision and allow them to see clearly. There is growing evidence in the medical literature to suggest that Atropine 0.01% eye drops can reduce the rate of myopia progression in children.

Atropine 1% is currently used as a diagnostic eye drop in some clinics to dilate the pupils and relax the focusing components of the eye to aid examination.  For Myopia management a much lower concentration of Atropine (0.01%) is used which is 100 times weaker than the dose currently used in clinic.


Moorfields Eye Hospital Dubai signs agreement with Noor Dubai Foundation

The strategic partnership is aimed at providing eye care services to treat UAE Patients with critical eye diseases. 

(Dubai, June 15 2022) In its latest effort to expand its reach in treatment of patients locally and expand its strategic partnerships, Noor Dubai Foundation signed a partnership agreement with Moorfields Eye Hospital Dubai (a branch of the renown Moorfields Eye Hospital, London) to provide treatment services to UAE based patients suffering from critical eye diseases and whose treatment requires special preparations to ensure maximum benefit from the treatment.

Launched in 2016, the UAE treatment program is one of Noor Dubai’s local outreach program aimed to facilitate treatment for UAE residents with critical eye diseases. Over the last 5 years, Noor Dubai has treated over 245 patients through this program creating a positive impact on the lives of the patients receiving treatment.

A UAE based charity, Noor Dubai was launched in 2008 by H.H. Sheikh Mohammed Bin Rashid Al Maktoum, Vice President & Prime Minister of the UAE & Ruler of Dubai. It is focused on the prevention of blindness and visual impairment globally. Since its launch, over 33 million patients from all over Africa and Asia have benefited from the Foundation’s free treatment and preventive programs, which includes provision of surgeries, eyeglasses, and medication.

Commenting on the partnership, Dr. Manal Taryam, CEO of Noor Dubai Foundation, said, “we are proud to collaborate with the private sector and in particular Moorfields Eye Hospital Dubai to strengthen development efforts in treating our patients in the UAE. We continuously strive to enhance cross sector collaborations between the humanitarian and the private sector through their CSR programs to improve the lives of our patients. This latest partnership is yet another testimonial to the Foundation’s global and local commitment to provide the best quality treatment and preventive services to fight visual impairment all over the world. We aim to work closely with the Moorfields team to explore other areas of synergies and drive collaborative efforts in the field of research and development. We also look forward to expanding the scope of partnerships with health care providers in the country, in order to facilitate access to and benefit from treatment services.”

Moorfields Eye Hospital Dubai Managing Director, Elhadi Hassan, said, “It is both an honor and a privilege for us to collaborate with Noor Dubai in their quest to treat preventable blindness, and we look forward to working more closely with them to raise the level of awareness of Noor Dubai’s honorable mission. We also look forward to exploring the potential of health education, training and research with this esteemed foundation.”

About Noor Dubai

Noor Dubai is an international charitable foundation working with partners to eliminate avoidable blindness and visual impairment around the world. It was established as a Foundation by decree law 18 in 2010.  The organization provides therapeutic, preventative, and educational programs to treat and prevent blindness in developing countries on a regional and international scale. To date, Noor Dubai has reached out to over 33 million individuals worldwide.

About Moorfields Eye Hospital Dubai

Moorfields Eye Hospital Dubai (MEHD) is the first overseas branch of Moorfields Eye Hospital NHS Foundation Trust, the oldest and one of the largest centres for ophthalmic treatment, teaching and research in the world. Located at the Al Razi Medical Complex in Dubai Health Care City, the facility provides day case surgery and outpatient diagnostic and treatment services, for a variety of surgical and non-surgical eye conditions. MEHD will also raise standards for research and teaching in the region. MEHD is owned and managed by the NHS Foundation Trust, and maintains close links with London, to ensure that patients in the GCC receive the best eye care treatment in the world.


New advance in glaucoma surgery with the Presserflo Microshunt

This  blog has been contributed Dr. Salman Waqar , Consultant in Ophthalmologist in Cataract and Glaucoma Surgery. 

Glaucoma occurs when the pressure in our eye becomes high leading to damage to the optic nerve (nerve that connects our eye to the brain and helps us see). It is important to lower the eye pressure urgently to protect the nerve.

This can be done with eye drops, lasers and surgical techniques. Usually eye drops and lasers are used as first line treatment, but if these are not effective we have to intervene surgically.


What is the Presserflo MicroShunt?

The MicroShunt is an 8 millimetre long tube that is inserted into the eye to help lower eye pressure in glaucoma and reduce the need for medication. It is made entirely of a synthetic and biocompatible material called SIBS.

The MicroShunt won’t be rejected by the body and will not disappear or disintegrate with time. As it is not metallic, it will not set off airport scanners and is safe if you need to have an MRI or CT scan.

How does it work?

Glaucoma is most commonly associated with a build-up of fluid pressure inside the eye. This build-up of fluid pressure is caused by partial blockage of the natural drainage channel of the eye. This pressure can damage the optic nerve which carries images from the eye to the brain affecting your vision. This fluid produced inside your eye is called aqueous humour, which is different from your tears. Like trabeculectomy surgery, the MicroShunt drains fluid from inside the eye to outside, under a thin skin-like membrane covering the white of the eye called conjunctiva. The fluid is drained and pooled under conjunctiva forming what is called a bleb.

What are the benefits?

The MicroShunt will lower your eye pressure and prevent further damage to the optic nerve caused by eye pressure (intraocular pressure).

Compared to other glaucoma procedures such as a trabeculectomy, MicroShunt has the advantage that the procedure is shorter, less invasive, and requires fewer post-operative visits. In addition, the drainage bleb created by the MicroShunt is usually less obvious than after a trabeculectomy and contact lens wearers are often still able to continue contact lens wear afterwards.

Are there any alternatives?

The closest alternatives to the MicroShunt will be a traditional trabeculectomy or aqueous shunt implant (Baerveldt, Ahmed or Paul Glaucoma Implant). We aim to always individualise treatment options to your unique needs and will suggest the MicroShunt to you only if we feel it offers the best chance of controlling your eye pressure using a minimally invasive approach.

Six effective ways to protect your eyes during summer

Whilst sun exposure is an excellent source of vitamin D, not taking the necessary protective measures during the summer can have damaging effects on the eyes.  Spending a lot of time under direct sun light and heat may accelerate the aging process of the eyes and lead to conditions such as cataracts and macular degeneration.

With temperatures reaching as high as 48°C in the UAE, our eyes are at risk of developing corneal burns, also known as photokeratitis. Therefore, it is extremely important to take the necessary precautions while enjoying summer activities in the sun.

Our Ophthalmologists share six effective tips to protect your eyes in the summer.


  1. Wear sunglasses with full UV protection – Increased exposure to UV radiation can damage the macula, a central part of the retina at the back of the eye, which gives us the ability to have the perfect, colored vision. UV radiation may also harm the front part of the eye (cornea and lens) leading to cataracts (clouding of lens), macular degeneration, pterygium (benign growth on the white of the eye) and corneal sunburn, which is painful and might cause temporary vision loss. Thus, medical grade tinted glasses that can block up to 100% of the sun’s UV radiations are essential for protecting your eyes in the summer.
  2. Lubricate your eyes – High temperatures and dry winds outdoors can lead to increased dry eye. Air conditioning use increases during summer which also leads to dry eye symptoms worsening. The best and most immediate way to address eye dryness is by using artificial tears to keep the eyes moist and refreshed.
  3. Nourish your body with antioxidants – Constant exposure to the sun’s rays can produce free radicals, roaming atoms in the body that can oxidize and damage the retina. Hence, consuming a diet that is rich in antioxidants will help cancel out the effects of free radicals. Antioxidants such as Lutein, zeaxanthin, and vitamins C can be found in oranges, berries and leafy vegetables and can be easily integrated into your diet.
  4. Stay hydrated – In general, drinking water is extremely important to maintain healthy functioning organs. Considering that the summer heat can make us lose more water through sweat, we need to drink more water to compensate for this loss. Also, if you drink diuretics such as coffee, consider drinking at least 2 litres of water per day. Dehydration is a leading cause of dry eye and irritation, so it is imperative to maintain balanced hydration levels during the summer months.
  5. Always wear swimming goggles – summer is synonymous with swimming. If you enjoy swimming, consider investing in goggles to protect your eyes. Pools are often disinfected with harsh sanitizers such as chlorine. Thus, using goggles can protect your eyes from coming in contact with potent sanitizers and reduce the likelihood of contracting an eye infection such as conjunctivitis, which leaves the surface of the eye red and dry.
  6. Avoid swimming with contacts – Another important precaution to take is to remove your contact lenses before swimming. In fact, swimming with contacts can have sight-threatening effects such as ulcers and infections. Additionally, pool or beach water is home to many microbes such as Acanthamoeba, which can result in infections in the eye and serious complications.

Moorfields Eye Hospitals UAE to host 4th Annual ‘A Year in Focus’ International Ophthalmology conference

Distinguished ophthalmologists from around the world will convene virtually to discuss advancements in the field and upcoming industry breakthroughs of 2022.    

Dubai, United Arab Emirates, December 2021: Moorfields Eye Hospitals UAE are delighted to announce the 4th edition of the ‘Moorfields UAE 2021 – A Year in Focus’ high caliber Ophthalmology conference that will take place virtually on Friday 14th and Saturday 15th January, 2022.

The conference will feature a stellar panel of 30+ prominent researchers, surgeons, and academics from across the world. They will be sharing the latest developments in Ophthalmology, in a highly engaging format.

Dr . Ammar Safar, Medical Director of Moorfields UAE and Chair in the conference said, “As a leader in Eye healthcare, Moorfields Eye Hospitals UAE have earned a reputation that reflects the passion for quality eye healthcare.  We are committed to sustaining and building on our pioneering legacy while remaining at the cutting edge of developments in all areas of ophthalmology. With the Ophthalmology conference, we not only aim to serve the local community, but also encourage the sharing of new ideas amongst peers.”

According to Mrs. Maha Aboughali, Conference organiser and Business Development and Marketing Director of Moorfields UAE,

“Industry professionals and stakeholders attending the event will be led through a journey of innovation in ophthalmology; they will learn about the latest developments in eye care emerging globally and what is yet to come”.

The two-day conference will be held in the format of nine themed sessions and will include updates in the fields of Vitreoretinal surgery, Medical Retina & Uveitis, Cornea, Refractive surgery, Glaucoma, Oculoplastic and Paediatrics, all presented by the experts in their fields.

Moreover, this edition of the conference will be seeing the first ever independent session for allied health professionals.

As an incentive, CME points will be awarded to attendees through DHA.

For more information and to register for the upcoming conference, interested participants can visit https://moorfields.e-vents.ae/

Ophthalmologists at Moorfields Eye Hospital Abu Dhabi restore vision for patient with Down Syndrome

4 September 2021 – Abu Dhabi, UAE: Ophthalmologists at Moorfields Eye Hospital Abu Dhabi, part of United Eastern Medical Services (UEMedical) and a Mubadala Health Partner, succeeded in restoring the vision of a 40-years old Emirati patient with Down Syndrome. The patient had one of her eyes removed at a younger age due to complications caused by a glaucoma surgery. Her vision in her only seeing eye began gradually deteriorating over the last 3 years and has recently lost almost all functional vision.

Since childhood, the patient has suffered from eye problems, and has experienced learning difficulties associated with Down syndrome. She underwent multiple surgeries to treat glaucoma in both eyes 15 years ago at one of the medical centers, but unfortunately, she suffered from some complications and lost vision in the left eye completely. The eye decreased drastically in size and was extremely painful, due to previous eye surgeries she had; thus, she underwent an eye removal procedure for her left eye.  

“The patient came to Moorfields Eye Hospital Abu Dhabi as her sight was worsening in her right eye – the only seeing eye. Her case was very complex as she was suffering from cataract, glaucoma, recurrent uveitis and lens iris adhesions from previous eye surgeries,” Dr. Igor Kozak, Clinical Lead and Ophthalmology Consultant at Moorfields Eye Hospital said. “At Moorfields Eye Hospital Abu Dhabi, we are fully equipped with the most advanced technologies according to international standards, and have top-notch ophthalmologists with the needed experience to treat the full spectrum of eye diseases in both adults and children with the best clinical outcomes. The hospital has always been providing care to people of determination and provides them with the care needed. This comes as part of UEMedical’s inclusion strategy, that ensures all our clinical and non-clinical members are fully trained to care for people of determination.”

Dr. Syed Ali, Consultant Ophthalmologist at Moorfields Abu Dhabi, who performed the surgery for the patient Aida, said, “Aida recently became completely dependent on her sisters due to severe sight impairment. She was unable to see her food on the plate. Walking in new places without help was also not possible for her.”

“The patient needed a cataract surgery and had severe lens iris adhesions. This required a surgical intervention to restore her vision and to enable ophthalmologists to monitor her optic nerve and retina which was not possible with her dense cataract. The surgery was performed at Moorfields Eye Hospital Abu Dhabi recently under general anesthesia as we needed to calm her down and make her comfortable. As a patient with Down syndrome who underwent several surgeries before, she developed fear of hospitals and procedures. The 1-hour surgery included removing her opaque natural lens and implanting an artificial lens inside the eye which helped in restoring her sight in the right eye completely. The procedure was complex because of the adhesions of the pupil and lens as a reaction to previous glaucoma surgeries and inflammation (recurrent uveitis). The latest techniques were used during the surgery. The pupil was detached from lens, then very dense cataract was removed and replaced with a new artificial lens which helped in restoring her sight to 6/6. She also required strong anti-inflammatory treatment after surgery. Her family members were worried about the surgery because it was the only hope that she sees them again because her left eye was removed long time back, otherwise she would’ve been left blind,” Dr. Syed Ali added. “Performing cataract surgery in patients with uveitis and previous intra-ocular surgery with lens and iris adhesion are always challenging and need meticulous care and planning before, during and after surgery. They require frequent follow for first 8 weeks after surgery to recognize any relapse of uveitis and treat early to avoid sight threatening complications.”

Ms. Asmaa Ahmed, the patient’s sister expressed her happiness and gratitude after the successful procedure which allowed her sister to see again. “Restoring her vision has helped her with her daily routines without depending on the help of others. For the past 2 years, she has required help in the most basic things such as walking, eating and moving around. Her reaction when the bandage was removed from her eye after surgery was very touching. She was extremely happy to see us again. She brought tears to the eyes of everyone in the room! On behalf of my family and sister, I would like to deeply thank the medical, technical and nursing teams at Moorfields Eye Hospital Abu Dhabi for their efforts with Aida since day one.”

Moorfields Eye Hospital highlights eye care Innovations at Arab Health

Dubai UAE: At the recent Arab Health 2021 conference, Moorfields Eye Hospital Dubai highlighted their upcoming research and innovation strategy and the hospital’s current and future plans.

Moorfields Eye Hospital Dubai, which opened in 2007, focused on the theme of this year’s conference which is ‘Research and Innovation’, a theme the hospital in Dubai and in London are continuously contributing towards to advance eye care.

At the conference, Dubai Healthcare City held an interview with Mr. Elhadi Hassan, Managing Director, Moorfields Eye Hospital Dubai, to learn more about the hospital’s current and future research and innovation plans.

During the interview, Mr. Elhadi said ‘Providing world class healthcare is one of the six pillars of the National Agenda of UAE and Moorfields Eye Hospital Dubai is continuously working towards applying the best practices in healthcare through its own research plans, involvement in higher education and providing access to world –renowned professionals in eye care’.

He added: ‘To support undergraduate ophthalmology education, research, and lifelong learning, Moorfields has a strategic partnership with the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). Moorfields’ ophthalmology physicians who hold adjunct academic titles at MBRU support students’ education by providing supervised clinical rotations and overseeing the ophthalmology curriculum.

Furthermore, on the topic of research, Mr. Elhadi highlighted:  ‘Moorfields is actively involved in research and our results have been presented at both national and international meetings and have been published in scientific ophthalmology literature. Research continues in the field of ocular epidemiology, imaging and therapy collaborating with national authorities to identify main causes of blindness and visual impairment in the UAE’.

And to end the interview, he spoke on the support the hospital provides patients ‘The Hospital has also formed support groups for patients with complex and lifelong eye problems. The groups acts as a safe place for patients to share their experiences and support one another’

For now, Moorfields Eye Hospital Dubai remains a leading hospital for eye health with a comprehensive range of eye care services offered through a team of specialist doctors and allied health professionals. The hospital occupies a  22,000 sq ft facility, housing three operating theatres and laser suite and 10 key departments equipped with the latest technology for diagnosis, management and treatment of all eye conditions The hospital also provides in-house pharmacy services and optical services in order to provide a truly holistic approach to their patient’s eye care needs.


Abu Dhabi, United Arab Emirates, 16th June 2021: Mubadala Health, the integrated healthcare network of Mubadala Investment Company, today announced the acquisition of a 60% stake in United Eastern Medical Services (UEMedical) from Jadwa Investment and United Eastern Group (UEG). UEMedical owns and operates multiple hospitals and clinics specializing in women’s health, family medicine, pediatrics, fertility, eye care, dentistry and dermatology in the UAE and KSA.

Through this acquisition, Mubadala Health adds Danat Al Emarat Hospital for Women & Children; the HealthPlus Network of Specialty Centers; HealthPlus Fertility, the largest IVF provider in the region; Moorfields Eye Hospital Abu Dhabi; and a stake in Al Meswak Dental Group to its network. The new services added to the Mubadala Health network include fertility & IVF, obstetrics, neonatology, and pediatric subspecialties.

Hasan Jasem Al Nowais, Chief Executive Officer of Mubadala Health, said: “Over the past decade, UEMedical has witnessed tremendous growth and success, operating facilities that have raised the bar in patient care across multiple specialties. This acquisition enhances Mubadala Health’s network in the UAE and the wider GCC region, while demonstrating our unwavering commitment to transforming the regional healthcare landscape by delivering a full range of healthcare services covering every phase of a patient’s life.”

Ahmed Ali Al-Shorafa Al-Hammadi, Managing Director of UEG, added: “As founders of UEMedical, we are proud of what UEMedical represents, and of our role in the evolution of the health sector through well-established accredited hospitals and clinics in various specialties. While it is not easy to exit what we have built, I believe Mubadala Health provides the best ecosystem to allow it to flourish. We wish Mubadala Health all the success in achieving their vision of a world-class healthcare ecosystem in the region.”

Tariq Al-Sudairy, Managing Director and CEO of Jadwa Investment, commented: “Our acquisition of UEMedical in 2016 came following an extensive assessment that revealed high growth potential for specialized health services, especially in the women and children space. We worked closely with the management team to realize the company’s ambitious growth strategy in the UAE and Saudi Arabia. We are very proud of our partnership with UEMedical shareholders and management, and wish Mubadala Health and the management team continued success in capturing the next phase of growth.”

Majd Abu Zant, CEO of UEMedical, said: “We are delighted to join Mubadala Health’s network of world-class healthcare providers. This acquisition drives innovation and clinical excellence, while expanding the continuum of care across the UAE and Saudi markets as part of an integrated healthcare ecosystem. UEMedical has always been patient-centric and embraces international partnerships that advance our expertise and attract healthcare professionals of the highest caliber. This approach aligns perfectly with that of Mubadala Health, and we look forward to the next phase of our journey.”

The transaction is anticipated to close by September 2021. Mubadala Health’s network currently includes Cleveland Clinic Abu Dhabi, Healthpoint, Imperial College London Diabetes Centre, Amana Healthcare, National Reference Laboratory, Capital Health Screening Centre, and Abu Dhabi Telemedicine Centre. Following completion, Mubadala Health’s portfolio will include more than 10,000 world-class caregivers delivering 100+ service lines across 15 prominent healthcare providers in the UAE and KSA.